Federal Grant Award Summary Texas A&M University System Health Science Center received a $675,247 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with a completion date of March 31, 2031. This research project investigates cholinergic dysregulation mechanisms in cocaine use disorder, specifically examining how cocaine-induced alterations in the dorsomedial striatum impair cognitive flexibility...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Texas at Austin a $1.21 million Project Grant on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop rigorous methodologies for evaluating computational neuroscience models against neural activity data. The project, titled "Representational Geometry: Evaluating Brain-Computational Models with Neural Activity Data," addresses the critical need...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $1.617 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, and concluding April 30, 2030. The grant supports research investigating the role of striatal molecular rhythms in sleep disruption and opioid use disorder (OUD) relapse vulnerability. The project utilizes innovative time-of-death computational...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1.54 million through its Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York, with performance at the University at Buffalo, Buffalo, NY. The award, obligated August 1, 2025, and extending through April 30, 2030, funds fundamental neuroscience research investigating the interplay between limbic norepinephrine (NE) and dopamine (DA) circuits...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $249,000 Project Grant to the University of Texas at Austin effective August 1, 2025, through July 31, 2028. This Pathway to Independence Award supports postdoctoral research led by Dr. Ayland Letsinger under the mentorship of Drs. Jerrel Yakel and Guohong Cui at the National Institute of Environmental Health Sciences. The research investigates...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant totaling $490,179 to the University of Texas at Austin on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the neurobiological mechanisms underlying fentanyl-induced elevations in risk-taking behavior. The research utilizes a rat model that incorporates both reward and punishment outcomes to recapitulate real-life decision-making processes. The...
Federal Grant Award Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Total Obligation: $780,961.00 Award Date: August 1, 2025 Project Period: August 1, 2025 – April 30, 2030 Recipient: New York University, New York, NY Research Deliverables: This Project Grant supports fundamental neuroscience research investigating multiregional brain computations underlying value-based decision-making...
Federal Project Grant Award Summary The University of Texas at Austin received a $159,625 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 1, 2025, and concluding June 30, 2027. This award supports basic research investigating age and sex differences in reward responding following punishment exposure, with the ultimate objective of establishing whether punishment serves as an effective deterrent for...
Federal Project Grant Award Summary Vanderbilt University received a $475,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 1, 2025, with a completion date of May 31, 2030. The award supports development and application of a platform technology called TAG-guided drug, which combines the dosability and reversibility of conventional pharmaceuticals with the molecular, spatial, and cellular...
Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Texas A&M University System Health Science Center a $635,002 Project Grant on June 15, 2026, to conduct fundamental neuroscience research on cholinergic modulation of striatal circuits in alcohol use disorder (AUD). The research will deliver scientific knowledge examining how chronic alcohol intake affects acetylcholine signaling in the dorsomedial striatum and the role of...
Federal Project Grant Award Summary
Texas A&M University received a $124,215 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of August 11, 2026, and completion target of February 28, 2029. This research project will investigate how circadian rhythms are integrated into neural circuitry governing reward-seeking behavior, specifically examining the bidirectional relationship between the ventral tegmental area (VTA) and nucleus accumbens (NAC)—two critical regions in the mesolimbic dopamine pathway. The research will employ selective ablation of circadian clock genes in these brain regions combined with long-term fiber photometry and behavioral assays to elucidate the fundamental neural mechanisms by which daily biological rhythms modulate reward-seeking behavior.
The project delivers fundamental neuroscience research addressing a critical gap in understanding how circadian timekeeping systems regulate reward neural circuitry. This work has significant implications for human health, as maladaptive reward behaviors underlie various neuropsychiatric disorders including addiction, bipolar disorder, and depression. The research is expected to advance therapeutic and diagnostic development for brain reward system disorders by establishing whether circadian rhythms in reward behavior arise from coordinated feedback loops between the VTA and NAC. Findings from this investigation will contribute to NIDA's broader research portfolio supporting basic, translational, and clinical research to develop new prevention, diagnosis, and treatment approaches for substance use disorders and related health outcomes.